AI & ChatGPT searches , social queriess for MTOR

Search references for MTOR. Phrases containing MTOR

See searches and references containing MTOR!

AI searches containing MTOR

MTOR

  • MTOR
  • Mammalian protein found in humans

    The mechanistic target of rapamycin (mTOR), also known as mammalian target of rapamycin is a serine-threonine protein kinase that regulates cell growth

    MTOR

    MTOR

    MTOR

  • MTOR inhibitors
  • Class of pharmaceutical drugs

    mTOR inhibitors are a class of drugs used to treat several human diseases, including cancer, autoimmune diseases, and neurodegeneration. They function

    MTOR inhibitors

    MTOR inhibitors

    MTOR_inhibitors

  • MTORC1
  • Protein complex

    controls protein synthesis. mTOR Complex 1 (mTORC1) is composed of the mTOR protein complex, regulatory-associated protein of mTOR (commonly known as raptor)

    MTORC1

    MTORC1

    MTORC1

  • PI3K/AKT/mTOR pathway
  • Cell cycle regulation pathway

    The PI3K/AKT/mTOR pathway is an intracellular signaling pathway important in regulating the cell cycle. Therefore, it is directly related to cellular quiescence

    PI3K/AKT/mTOR pathway

    PI3K/AKT/mTOR pathway

    PI3K/AKT/mTOR_pathway

  • MTORC2
  • Protein complex

    mTOR Complex 2 (mTORC2) is an acutely rapamycin-insensitive protein complex formed by serine/threonine kinase mTOR that regulates cell proliferation and

    MTORC2

    MTORC2

  • Sirolimus
  • Pharmaceutical drug

    rejection of kidney transplants. It is a mammalian target of rapamycin (mTOR) kinase inhibitor that reduces the sensitivity of T cells and B cells to

    Sirolimus

    Sirolimus

    Sirolimus

  • P70-S6 Kinase 1
  • Protein-coding gene in the species Homo sapiens

    of p70S6K at threonine 389 has been used as a hallmark of activation by mTOR and correlated with autophagy inhibition in various situations.[citation

    P70-S6 Kinase 1

    P70-S6 Kinase 1

    P70-S6_Kinase_1

  • Smith–Kingsmore syndrome
  • Medical condition

    rare genetic disorder that is caused by a gain-of-function mutation in a mTOR gene. The facial features of this syndrome are triangular face with a pointed

    Smith–Kingsmore syndrome

    Smith–Kingsmore syndrome

    Smith–Kingsmore_syndrome

  • Philadelphia chromosome
  • Genetic abnormality in leukemia cancer cells

    cellular processes. Additionally, mTOR can act both upstream and downstream of AKT. Two multiprotein complexes of mTOR are involved in the PAM pathway,

    Philadelphia chromosome

    Philadelphia chromosome

    Philadelphia_chromosome

  • Autism
  • Condition involving social and behavioral differences

    cells in post-mortem brain tissue. Genes associated with variation in the mTOR signaling pathway, which is involved in cell growth and survival, are also

    Autism

    Autism

    Autism

  • Gedatolisib
  • Chemical compound

    nutrients.  mTOR protein is found in two functionally distinct protein assemblies: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). mTOR signaling serves

    Gedatolisib

    Gedatolisib

    Gedatolisib

  • David M. Sabatini
  • American scientist who co-discovered mTOR

    of cell signaling and cancer metabolism, most notably the co-discovery of mTOR. In 2021 and 2022, Sabatini was fired from the Howard Hughes Medical Institute

    David M. Sabatini

    David M. Sabatini

    David_M._Sabatini

  • Branched-chain amino acid
  • Amino acid with a branched carbon chain

    is a downstream component of the mammalian target of rapamycin complex (mTOR) pathway, which regulates adaptive hypertrophy and recovery in skeletal muscle

    Branched-chain amino acid

    Branched-chain amino acid

    Branched-chain_amino_acid

  • Focal cortical dysplasia
  • Failure of certain neurons to migrate during brain development

    mammalian target of rapamycin (mTOR) pathway. Causative gene mutations for types 1 and 3 have not been identified. The mTOR pathway regulates a number of

    Focal cortical dysplasia

    Focal cortical dysplasia

    Focal_cortical_dysplasia

  • List of S&P 600 companies
  • acquired by Blackstone Inc. August 4, 2022 AHCO AdaptHealth MTOR Meritor AHCO replaced MTOR after it was acquired by Cummins. July 26, 2022 SIX Six Flags

    List of S&P 600 companies

    List_of_S&P_600_companies

  • Glioblastoma
  • Aggressive type of brain cancer

    intracellular signaling system known as phosphatidylinositol-3-OH kinase (PI3K)/AKT/mTOR, which is crucial for controlling cell survival. The third pathway is defined

    Glioblastoma

    Glioblastoma

    Glioblastoma

  • Synaptic pruning
  • Process of synapse elimination

    during development; these changes have been linked to hyperactivation of the mTOR pathway and defective autophagy in neurons. Neuroplasticity Faust, Travis

    Synaptic pruning

    Synaptic pruning

    Synaptic_pruning

  • Ketamine
  • Dissociative anesthetic and anti-depressant

    the NMDA receptor and downstream effects on regulators such as BDNF and mTOR. It is not clear whether ketamine alone is sufficient for antidepressant

    Ketamine

    Ketamine

    Ketamine

  • Leucine
  • Chemical compound

    target of rapamycin (mTOR), a serine-threonine protein kinase that regulates protein biosynthesis and cell growth. The activation of mTOR by leucine is mediated

    Leucine

    Leucine

    Leucine

  • Late endosomal/lysosomal adaptor, mapk and mtor activator 1
  • Protein-coding gene in the species Homo sapiens

    Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 is a protein that in humans is encoded by the LAMTOR1 gene. GRCh38: Ensembl release 89: ENSG00000149357

    Late endosomal/lysosomal adaptor, mapk and mtor activator 1

    Late endosomal/lysosomal adaptor, mapk and mtor activator 1

    Late_endosomal/lysosomal_adaptor,_mapk_and_mtor_activator_1

  • Huntington's disease
  • Inherited neurodegenerative disorder

    Berger Z, Davies JE, Luo S, Oroz LG, et al. (June 2004). "Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly

    Huntington's disease

    Huntington's disease

    Huntington's_disease

  • Epithelioid sarcoma
  • Medical condition

    frequent overactivation of mTOR (mammalian target of rapamycin) signaling has also been observed in epithelioid sarcoma. The mTOR pathway has been described

    Epithelioid sarcoma

    Epithelioid sarcoma

    Epithelioid_sarcoma

  • Fibrosis
  • Excess connective tissue in healing

    10 (IL-10). These initiate signal transduction pathways such as the AKT/mTOR and SMAD pathways that ultimately lead to the proliferation and activation

    Fibrosis

    Fibrosis

    Fibrosis

  • Muscle hypertrophy
  • Enlargement or overgrowth of a muscle organ

    mechanical tension. Mechanical tension is known to activate pathways such as mTOR, which is responsible for protein synthesis, a mechanism that directly contributes

    Muscle hypertrophy

    Muscle hypertrophy

    Muscle_hypertrophy

  • Exercise
  • Physical activity that improves health

    "The neurology of mTOR". Neuron. 84 (2): 275–291. doi:10.1016/j.neuron.2014.09.034. PMC 4223653. PMID 25374355. Figure 2: The mTOR Signaling Pathway Wang

    Exercise

    Exercise

    Exercise

  • Lymphangioleiomyomatosis
  • Progressive cystic lung disease

    and controls the activity of mTOR complex 1 (mTORC1) that directly phosphorylates p70 S6 kinase (S6K1) and 4E-BP1. mTOR forms two physically and functionally

    Lymphangioleiomyomatosis

    Lymphangioleiomyomatosis

    Lymphangioleiomyomatosis

  • Sertraline
  • SSRI antidepressant

    transporter is uncertain. Sertraline is a REDD1-dependent mTOR inhibitor. It blocks AKT/mTOR pathway and has autophagy-inducing activity. Following a single

    Sertraline

    Sertraline

    Sertraline

  • Benign tumor
  • Mass of cells which cannot spread throughout the body

    hamartin inhibit the mTOR protein in normal cellular physiology. Inactivation of the TSC tumor suppressors causes an increase in mTOR activity. This leads

    Benign tumor

    Benign tumor

    Benign_tumor

  • LAMTOR4
  • Protein-coding gene in the species Homo sapiens

    Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 is a protein that in humans is encoded by the LAMTOR4 gene. GRCh38: Ensembl release 89: ENSG00000188186

    LAMTOR4

    LAMTOR4

    LAMTOR4

  • Pancreatic cancer
  • Type of endocrine gland cancer

    develop a PanNet. Other genes that are frequently mutated include DAXX, mTOR, and ATRX. Medical imaging techniques, such as computed tomography (CT scan)

    Pancreatic cancer

    Pancreatic cancer

    Pancreatic_cancer

  • Rapalink-1
  • Pharmaceutical compound

    which acts as an inhibitor of the enzyme mechanistic target of rapamycin (mTOR). It is a dimeric molecule consisting of rapamycin joined to a desalkyl derivative

    Rapalink-1

    Rapalink-1

    Rapalink-1

  • Lung cancer
  • Malignant tumor characterized by uncontrolled cell growth in lung tissue

    (17% of trials), microtubules (12%), VEGF (12%), immune pathways (10%), mTOR (1%), and histone deacetylases (<1%). "Carcinoma, Non-Small-Cell Lung". meshb

    Lung cancer

    Lung cancer

    Lung_cancer

  • Itaconic acid
  • Chemical compound

    treatment of the Ty82 cells decreased the activity of their mTOR protein as well as PI3K/AKT/mTOR pathway (This pathway promotes the development and/or progression

    Itaconic acid

    Itaconic acid

    Itaconic_acid

  • Notch signaling pathway
  • Series of molecular signals

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Notch signaling pathway

    Notch signaling pathway

    Notch_signaling_pathway

  • Titin
  • Largest known protein in human muscles

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    Titin

    Titin

    Titin

  • Β-Hydroxy β-methylbutyric acid
  • Chemical compound

    skeletal muscle via phosphorylation of the mechanistic target of rapamycin (mTOR) and subsequent activation of mTORC1Tooltip mechanistic target of rapamycin

    Β-Hydroxy β-methylbutyric acid

    Β-Hydroxy β-methylbutyric acid

    Β-Hydroxy_β-methylbutyric_acid

  • List of signalling pathways
  • pathway MAPK/ERK signalling pathway mTOR signalling pathway Nodal signalling pathway Notch signalling pathway PI3K/AKT/mTOR signalling pathway TGF beta signalling

    List of signalling pathways

    List_of_signalling_pathways

  • Osavampator
  • Experimental antidepressant

    the AMPA receptor, downstream activation of mammalian target of rapamycin (mTOR), and upregulation of brain-derived neurotrophic factor (BDNF) are central

    Osavampator

    Osavampator

    Osavampator

  • Juxtacrine signalling
  • Contact-based cell-cell signalling

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Juxtacrine signalling

    Juxtacrine signalling

    Juxtacrine_signalling

  • Sarcosine
  • Amino acid

    sarcosine has been shown to modulate AMPA receptor function and downstream mTOR signalling in rodent models of depression. Long-term sarcosine administration

    Sarcosine

    Sarcosine

    Sarcosine

  • Ibogaine
  • Psychoactive substance found in plants in the family Apocynaceae

    be blocked by the serotonin 5-HT2A receptor antagonist ketanserin, by the mTOR inhibitor rapamycin, and by a TrkB antagonist. Ibogaine is metabolized in

    Ibogaine

    Ibogaine

    Ibogaine

  • Hormone
  • Biological signalling molecule

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Hormone

    Hormone

    Hormone

  • MAP kinase kinase kinase kinase
  • Family of proteins

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    MAP kinase kinase kinase kinase

    MAP_kinase_kinase_kinase_kinase

  • Tuberous sclerosis
  • Genetic condition causing non-cancerous tumours

    An mTOR inhibitor drug can help, though a lung transplant may be required. A 12-lead ECG should be performed every three to five years. The mTOR inhibitor

    Tuberous sclerosis

    Tuberous sclerosis

    Tuberous_sclerosis

  • Apoptosis
  • Form of programmed cell death

    Necrotaxis Nemosis Mitotic catastrophe p53 Paraptosis Pseudoapoptosis PI3K/AKT/mTOR pathway Ruptosis Note that the average human adult has more than 13 trillion

    Apoptosis

    Apoptosis

    Apoptosis

  • Immunosuppressive drug
  • Drug that inhibits activity of immune system

    active against tumors that are PI3K/AKT/mTOR-dependent. Everolimus is an analog of sirolimus and also is an mTOR inhibitor. Zotarolimus is a semi-synthetic

    Immunosuppressive drug

    Immunosuppressive drug

    Immunosuppressive_drug

  • Torin-1
  • Chemical compound

    first non-rapalog derived inhibitors of the mechanistic target of rapamycin (mTOR) subtypes mTORC1 and mTORC2. In animal studies it has anti-inflammatory,

    Torin-1

    Torin-1

    Torin-1

  • Scleroderma
  • Group of autoimmune diseases resulting in abnormal growth of connective tissue

    hearing loss) and progressive multifocal leucoencephalopathy. Sirolimus mTOR inhibitor, thereby reducing cytokine-induced lymphocyte proliferation. PO

    Scleroderma

    Scleroderma

    Scleroderma

  • David Fajgenbaum
  • American immunologist, author (born 1985)

    In 2014, he discovered increased mTOR signaling in idiopathic multicentric Castleman disease and began testing an mTOR inhibitor on himself to assess its

    David Fajgenbaum

    David Fajgenbaum

    David_Fajgenbaum

  • G protein
  • Type of proteins

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    G protein

    G protein

    G_protein

  • The Cancer Genome Atlas
  • Project to catalogue genetic mutations responsible for cancer

    modifications resulting in global hypomethylation, and genes of the PI3K/AKT/mTOR pathway; metabolic shift similar to the 'Warburg effect' correlates with

    The Cancer Genome Atlas

    The_Cancer_Genome_Atlas

  • Autophagy
  • Process of cells digesting parts of themselves

    and reactive oxygen species regulate the activity of the protein kinases mTOR and AMPK. These two kinases regulate autophagy through inhibitory phosphorylation

    Autophagy

    Autophagy

    Autophagy

  • Immunometabolism
  • interplay of these molecules. mTOR is a serine/threonine protein kinase, which is found in 2 complexes in cells: mTOR complex 1 and 2 (mTORC1 and mTORC2)

    Immunometabolism

    Immunometabolism

  • Phosphoinositide 3-kinase
  • Class of enzymes

    DNA-dependent protein kinase (DNA-PK) and mammalian target of rapamycin (mTOR). They are protein serine/threonine kinases. The various 3-phosphorylated

    Phosphoinositide 3-kinase

    Phosphoinositide 3-kinase

    Phosphoinositide_3-kinase

  • Endometrial cancer
  • Uterine cancer that is located in tissues lining the uterus

    inhibit the mTOR pathway may reduce the risk of disease worsening compared to having more chemotherapy or hormonal therapy. However, mTOR inhibitors may

    Endometrial cancer

    Endometrial cancer

    Endometrial_cancer

  • Transplant rejection
  • Rejection of transplanted tissue by the recipient's immune system

    anti-proliferative agent. Where calcineurin inhibitors or steroids are contraindicated, mTOR inhibitors are used. Immunosuppressive drugs: Corticosteroids Prednisolone

    Transplant rejection

    Transplant rejection

    Transplant_rejection

  • Naegleria fowleri
  • Species of protozoa

    inhibits the pathogen via disrupting its cell survival signal pathway PI3K/Akt/mTOR, has been used in a few cases with mixed results. Other treatments include

    Naegleria fowleri

    Naegleria fowleri

    Naegleria_fowleri

  • Everolimus
  • Chemical compound

    similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR). It is marketed by Novartis under the trade names Zortress (US) and Certican

    Everolimus

    Everolimus

    Everolimus

  • Vepdegestrant
  • Chemical compound

    demonstrated synergistic effects when combined with CDK4/6 inhibitors or PI3K/mTOR pathway inhibitors in preclinical ER+ breast cancer models. The US Food and

    Vepdegestrant

    Vepdegestrant

    Vepdegestrant

  • Sarcopenia
  • Early onset muscle loss due to ageing or immobility

    synthesis. It is reported to have multiple targets, including stimulating mTOR and decreasing proteasome expression. Its use to prevent the loss of lean

    Sarcopenia

    Sarcopenia

    Sarcopenia

  • Transforming growth factor beta
  • Cytokine

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Transforming growth factor beta

    Transforming growth factor beta

    Transforming_growth_factor_beta

  • Epilepsy
  • Group of neurological disorders causing seizures

    implications. Mutations in genes affecting ion channels, synaptic transmission, and mTOR signaling pathways have been linked to epilepsy syndromes, and molecular

    Epilepsy

    Epilepsy

    Epilepsy

  • Phosphoinositide 3-kinase inhibitor
  • Medical drug glass

    phosphoinositide 3-kinase (PI3K) enzymes, which are part of the PI3K/AKT/mTOR pathway. This signal pathway regulates cellular functions such as growth

    Phosphoinositide 3-kinase inhibitor

    Phosphoinositide 3-kinase inhibitor

    Phosphoinositide_3-kinase_inhibitor

  • Acetate kinase
  • Class of enzymes

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    Acetate kinase

    Acetate kinase

    Acetate_kinase

  • Lysine malonylation
  • Post-translational modification

    endothelial cells, leading to lysine malonylation of mTOR at lysine 1218. This impairs the kinase activity of mTOR complex 1, which reduces endothelial proliferation

    Lysine malonylation

    Lysine malonylation

    Lysine_malonylation

  • Quorum sensing
  • Biological ability to detect and respond to cell population density

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Quorum sensing

    Quorum_sensing

  • Senescence-associated secretory phenotype
  • Phenotype of senescent cells which secrete certain substances

    for IL1A is highly dependent upon mTOR activity. mTOR activity increases levels of IL1A, mediated by MAPKAPK2. mTOR inhibition of ZFP36L1 prevents this

    Senescence-associated secretory phenotype

    Senescence-associated_secretory_phenotype

  • Neurotransmitter
  • Chemical substance that enables neurotransmission

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Neurotransmitter

    Neurotransmitter

    Neurotransmitter

  • Right ventricular hypertrophy
  • Medical condition

    only cause of RVH. Hypertrophy can also be caused by mechanical forces, mTOR pathways, nitric oxide and immune cells. Immune cells can cause hypertrophy

    Right ventricular hypertrophy

    Right ventricular hypertrophy

    Right_ventricular_hypertrophy

  • Ketamine/temsirolimus
  • Pharmaceutical compound

    receptor antagonist, and temsirolimus, a mammalian target of rapamycin (mTOR) inhibitor, which is under development for the treatment of major depressive

    Ketamine/temsirolimus

    Ketamine/temsirolimus

    Ketamine/temsirolimus

  • DEPTOR
  • Protein-coding gene in the species Homo sapiens

    DEP domain-containing mTOR-interacting protein (DEPTOR) also known as DEP domain-containing protein 6 (DEPDC6) is a protein that in humans is encoded by

    DEPTOR

    DEPTOR

    DEPTOR

  • Serotonin
  • Monoamine neurotransmitter

    protein serotonylation substrates include several metabolic enzymes (GAPDH, mTOR), Rab GTPases (Rab3a, Rab27a), Rho GTPases (RhoA, Rac1, Cdc42), proteins

    Serotonin

    Serotonin

    Serotonin

  • Progeria
  • Genetic disorder that causes early aging

    it now has a more normal state.[citation needed] Studies of sirolimus, an mTOR Inhibitor, demonstrate that it can minimize the phenotypic effects of progeria

    Progeria

    Progeria

    Progeria

  • Protein kinase A
  • Family of enzymes

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    Protein kinase A

    Protein kinase A

    Protein_kinase_A

  • Pancreatic neuroendocrine tumor
  • Tumors of the nervous or endocrine system within the pancreas

    mutations in mTOR pathway genes, such as TSC2, PTEN and PIK3CA. The sequencing discovery might allow selection of which NETs would benefit from mTOR inhibition

    Pancreatic neuroendocrine tumor

    Pancreatic neuroendocrine tumor

    Pancreatic_neuroendocrine_tumor

  • Folliculin
  • Protein-coding gene

    regulator of mechanistic target of rapamycin (mTOR) suggesting that FLCN and FNIP1 may play a role in modulating mTOR activity through energy- or nutrient-sensing

    Folliculin

    Folliculin

    Folliculin

  • Cannabidiorcol
  • Phytocannabinoid

    TRPV2 promotes tumorigenesis through the pathways of HSP70/27 and PI3K/Akt/mTOR in esophageal squamous cell carcinoma". British Journal of Cancer. 127 (8):

    Cannabidiorcol

    Cannabidiorcol

    Cannabidiorcol

  • Sapanisertib
  • Chemical compound

    MLN0128, INK128 and TAK-228) is an experimental small molecule inhibitor of mTOR which is administered orally. It targets both mTORC1 and mTORC2. Developed

    Sapanisertib

    Sapanisertib

    Sapanisertib

  • Extracellular signal-regulated kinases
  • Class of enzymes

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    Extracellular signal-regulated kinases

    Extracellular_signal-regulated_kinases

  • Pyruvate dehydrogenase kinase
  • Class of enzymes

    SGK2 SGK3 Protein kinase B AKT1 AKT2 AKT3 Ataxia telangiectasia mutated mTOR EIF-2 kinases PKR HRI EIF2AK3 EIF2AK4 Wee1 WEE1 Pyruvate dehydrogenase kinase

    Pyruvate dehydrogenase kinase

    Pyruvate dehydrogenase kinase

    Pyruvate_dehydrogenase_kinase

  • Hallmarks of aging
  • Types of irreversible biochemical changes

    well-studied among them the mTOR pathway. When energy and nutrients are scarce, the AMPK receptor senses this and switches off mTOR to conserve resources.

    Hallmarks of aging

    Hallmarks_of_aging

  • Birt–Hogg–Dubé syndrome
  • Rare autosomal dominant cancer syndrome

    involvement with cellular metabolism, possibly through modulation of the mTOR (mammalian target of rapamycin) pathway and/or oxidative phosphorylation

    Birt–Hogg–Dubé syndrome

    Birt–Hogg–Dubé syndrome

    Birt–Hogg–Dubé_syndrome

  • Longevity
  • Longer than typical lifespan, especially of humans

    influence longevity are Insulin/IGF-1, mechanistic target of rapamycin (mTOR), AMP-activating protein kinase (AMPK), and Sirtuin pathways. Emerging research

    Longevity

    Longevity

    Longevity

  • Second messenger system
  • System of signaling molecules within a cell

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Second messenger system

    Second_messenger_system

  • Sammy Basso
  • Italian biologist and writer with progeria (1995–2024)

    Lattanzi, Giovanna (November 2016). "Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders". British

    Sammy Basso

    Sammy_Basso

  • Chordoma
  • Type of spinal cancer

    association with tuberous sclerosis complex (TSC1 or TSC2) has been suggested. mTOR signaling is hyperactive in sporadic sacral chordomas: in one study 10 out

    Chordoma

    Chordoma

    Chordoma

  • Meritor
  • American truck parts manufacturer

    Formerly ArvinMeritor (2000–2011) Company type Subsidiary Traded as NYSE: MTOR (delisted 2022) Industry Commercial vehicles systems and components Predecessor

    Meritor

    Meritor

  • Diffuse large B-cell lymphoma
  • Type of blood cancer

    neoplastic cells in DLBCL, NOS exhibit pathologically overactive NF-κB, PI3K/AKT/mTOR, JAK-STAT0, MAPK/ERK, B-cell receptor, toll-like receptor, and NF-κB signaling

    Diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma

    Diffuse_large_B-cell_lymphoma

  • Phakomatosis
  • Medical condition

    the RAS–mitogen-activated protein kinase (MAPK) pathway and the PI3K/AKT/mTOR pathway that regulates cellular growth, differentiation, proliferation and

    Phakomatosis

    Phakomatosis

  • Receptor tyrosine kinase
  • Class of enzymes

    RTK TGF beta MAPK/ERK Notch JAK-STAT Akt/PKB Fas apoptosis Hippo PI3K/AKT/mTOR pathway Integrin receptors Agents Receptor ligands Hormones

    Receptor tyrosine kinase

    Receptor tyrosine kinase

    Receptor_tyrosine_kinase

  • Cartilage
  • Resilient and smooth elastic tissue present in animals

    Tariq M. (2018-09-05). "Butein Activates Autophagy Through AMPK/TSC2/ULK1/mTOR Pathway to Inhibit IL-6 Expression in IL-1β Stimulated Human Chondrocytes"

    Cartilage

    Cartilage

    Cartilage

  • Herpesviridae
  • Family of DNA viruses

    activates PI3K which in turn activates PKB (Akt). PKB may then activate mTOR, which may target Stat3 for phosphorylation on the S727 residue. Another

    Herpesviridae

    Herpesviridae

    Herpesviridae

  • Alectinib
  • ALK inhibitor for treatment of non-small-cell lung cancer

    subsequently blocks cell signalling pathways, including STAT3 and the PI3K/AKT/mTOR pathway, and induces death (apoptosis) of tumour cells. When taken with a

    Alectinib

    Alectinib

    Alectinib

  • Disposable soma theory of aging
  • Model of aging as a trade-off between growth, reproduction, and DNA maintenance

    chaperones, and heat-shock proteins. Additionally, uptake of IGF-1 stimulates the mTOR pathway, which activates protein synthesis (and therefore growth) through

    Disposable soma theory of aging

    Disposable_soma_theory_of_aging

  • Brian K. Kennedy
  • American biologist

    Kaeberlein, he published seminal reports identifying the importance of the mTOR pathway in regulating longevity. In 2010, joined the Buck Institute for Research

    Brian K. Kennedy

    Brian_K._Kennedy

  • Lysosome
  • Cell membrane organelle

    sensing nutrient availability. When nutrients are plentiful, they activate mTOR signaling to support anabolic (biosynthetic) processes. During starvation

    Lysosome

    Lysosome

    Lysosome

  • Sjöberg Prize
  • Award

    Brian Druker American 2020 Michael N. Hall American “for their discovery of mTOR and its role in the control of cell metabolism and growth.” David M. Sabatini

    Sjöberg Prize

    Sjöberg_Prize

  • EIF4EBP1
  • Protein-coding gene in the species Homo sapiens

    Phosphorylated 4E-BP1 is thought to be a marker of upstream signaling (mTOR) activation. 4E-BP1 has seven phospho-sites, the three most important of

    EIF4EBP1

    EIF4EBP1

    EIF4EBP1

  • Ragulator-Rag complex
  • Aspect of cell metabolism

    Complex is composed of five LAMTOR subunits, which work to regulate MAPK and mTOR complex 1. The LAMTOR subunits form a complex with Rag GTPase and v-ATPase

    Ragulator-Rag complex

    Ragulator-Rag complex

    Ragulator-Rag_complex

  • NDRG1
  • Protein-coding gene in the species Homo sapiens

    Blaes J, Pusch S, Sahm F, Czabanka M, Luger S, et al. (January 2014). "mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy"

    NDRG1

    NDRG1

    NDRG1

AI & ChatGPT searchs for online references containing MTOR

MTOR

AI search references containing MTOR

MTOR

AI search queriess for Facebook and twitter posts, hashtags with MTOR

MTOR

Follow users with usernames @MTOR or posting hashtags containing #MTOR

MTOR

Online names & meanings

  • Insol
  • Girl/Female

    Indian, Tamil

    Insol

    Sweet Words

  • Sulakshana | ஸுலக்ஷணா
  • Girl/Female

    Tamil

    Sulakshana | ஸுலக்ஷணா

    Well brought up, Fortunate

  • Angadh
  • Boy/Male

    Indian, Telugu

    Angadh

    Strength

  • Karka
  • Girl/Female

    Gujarati, Hindu, Indian, Kannada, Malayalam, Marathi, Sanskrit, Telugu

    Karka

    Crab

  • Adelle
  • Girl/Female

    German American French

    Adelle

    Sweet or noble.

  • Hemita
  • Girl/Female

    Hindu, Indian

    Hemita

    Covered with Gold

  • Peralagan
  • Boy/Male

    Indian, Tamil

    Peralagan

    Very Handsome

  • Muizzuddawlah
  • Boy/Male

    Arabic, Muslim

    Muizzuddawlah

    He who Renders the State Mighty

  • Bhavagnya
  • Girl/Female

    Indian, Telugu

    Bhavagnya

    One of Name of Goddess Lalitha Devi

  • Sadoof
  • Girl/Female

    Muslim/Islamic

    Sadoof

    Name of a poetess

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with MTOR

MTOR

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing MTOR

MTOR

AI searchs for Acronyms & meanings containing MTOR

MTOR

AI searches, Indeed job searches and job offers containing MTOR

Other words and meanings similar to

MTOR

AI search in online dictionary sources & meanings containing MTOR

MTOR